Search Results
Results 1 - 10 of 18
(page 1 of 2)
Adalimumab, alefacept, efalizumab, etanercept, and infliximab for severe psoriasis vulgaris in adults budget impact analysis and review of comparative clinical- and cost-effectiveness
E-book
E-book
| Publisher: | Ottawa, Ont. : Canadian Agency for Drugs and Technology in Health, 2007 |
| Phys. Desc.: | 1 electronic text (v, 40 p. : tables) : digital file. |
| Electronic resource: | desLibris e-book: |
Infliximab versus methotrexate, etanercept, adalimumab, and ustekinumab for plaque psoriasis a review of the comparative clinical efficacy, safety and cost effectiveness
E-book
E-book
| Publisher: | [Ottawa, Ont.] : Canadian Agency for Drugs and Technologies in Health, 2012 |
| Phys. Desc.: | 1 electronic text (25 p.) : tables, digital file. |
| Electronic resource: | desLibris e-book: |
Palivizumab prophylaxis against respiratory syncytial virus
E-book
E-book
| Publisher: | Ottawa, Ont. : Canadian Agency for Drugs and Technologies in Health, 2007 |
| Phys. Desc.: | 1 electronic text (v, 9 p.) : digital file. |
| Electronic resource: | desLibris e-book: |
Denosumab and zoledronic acid for patients with postmenopausal osteoporosis a review of the clinical effectiveness, safety, cost effectiveness, and guidelines
E-book
E-book
| Publisher: | [Ottawa, Ont.] : Canadian Agency for Drugs and Technologies in Health, 2012 |
| Phys. Desc.: | 1 electronic text (20 p.) : tables, digital file. |
| Electronic resource: | desLibris e-book: |
Infliximab versus adalimumab for patients with moderate to severe ulcerative colitis a clinical and cost effectiveness review
E-book
E-book
| Publisher: | Ottawa, Ont. : Canadian Agency for Drugs and Technologies in Health, 2008 |
| Phys. Desc.: | 1 electronic text (9 p.) : tables, digital file. |
| Electronic resource: | desLibris e-book: |
Anti-TNF-[alpha] drugs for refractory inflammatory bowel disease clinical- and cost-effectiveness analyses
E-book
E-book
| Publisher: | Ottawa, Ont. : Canadian Agency for Drugs and Technologies in Health = Agence canadienne des médicaments et des technologies de la santé, 2009 |
| ISBN: | 9781897465912 (electronic bk.) |
| Phys. Desc.: | 1 electronic text (xi, 72, A-117 p.) : ill., digital file. |
| Electronic resource: | desLibris e-book: |
Omalizumab treatment for adults and children with allergic asthma : a review of the clinical effectiveness, cost-effectiveness, and guidelines
E-book
E-book
| Publisher: | Ottawa, Ontario : Canadian Agency for Drugs and Technology in Health, 2015. |
| Phys. Desc.: | 1 electronic text (24 pages) : tables. |
| Electronic resource: | desLibris e-book: |
The role of trastuzumab in adjuvant and neoadjuvant therapy in women with HER2/neu-overexpressing breast cancer
E-book
E-book
| Publisher: | Toronto, Ontario : Cancer Care Ontario, 2011. |
| Phys. Desc.: | 1 electronic text (45 pages in various pagings). |
| Electronic resource: | desLibris e-book: |
A vast injustice investigation into the Ministry of Health and Long-Term Care's decision-making concerning the funding of Avastin for colorectal cancer patients
E-book
E-book
| Publisher: | [Toronto, Ont.] : Ombudsman Ontario, 2009 |
| Phys. Desc.: | 1 electronic text (44, 3 p.) : digital file. |
| Electronic resource: | desLibris e-book: |
Bevacizumab for the treatment of patients with glioblastoma multiforme that has relapsed or progressed following prior therapy
E-book
E-book
| Publisher: | Toronto, Ontario : Cancer Care Ontario, 2010. |
| Phys. Desc.: | 1 electronic text (iv, 16 pages). |
| Electronic resource: | desLibris e-book: |
